GILD - Gilead has strong Q1 but updated 2024 EPS guidance range misses consensus
2024-04-25 18:55:25 ET
More on Gilead Sciences
- Gilead Q1 Earnings Preview: Most Gains Wiped Out - Cause For Concern?
- Gilead Sciences: Some Signs Of An Impending Bottom
- Gilead Sciences Finally Starts Succeeding
- Gilead Sciences Non-GAAP EPS of -$1.32 beats by $0.20, revenue of $6.69B beats by $350M
- Gilead Sciences Q1 Preview: HIV pipeline, FY24 guidance in focus